Practice
Featured experience
Bristol Myers Squibb $13 billion notes offering
The investment-grade offering comprised nine tranches
Cisco Systems $13.5 billion notes offering
The investment-grade offering comprises seven tranches of notes
Galderma Group CHF2.3 billion ($2.6 billion) IPO
We advised Galderma on its IPO
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering
Kosmos Energy $500 million notes offering and concurrent tender offers
We advised Kosmos on the senior notes offering and concurrent tender offers
Ryan Specialty $600 million notes offering and $3.1 billion credit facilities
The company also obtained a $500 million bridge facility commitment
Labcorp $2 billion senior notes offering
The investment-grade notes are due 2030, 2032 and 2034
Chewy $500 million secondary offering
The shares are listed on the New York Stock Exchange
Voya Financial $400 million senior notes offering
The investment-grade notes are due 2034
MicroStrategy $1.01 billion convertible notes offering
The convertible notes are due 2028
Great Elm Capital Corp. $36 million notes offering
We advised Great Elm Capital on the offering
Macy’s $220 million tender offers
The cash tender offers applied to certain series of outstanding notes
CSX $550 million senior notes offering
We advised CSX on the investment-grade debt offering
Novartis $3.7 billion notes offering
We advised Novartis on the investment-grade debt offering